NCT00605215 · Interventional trial
BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Overall registry status Completed
Phase 3
Conditions Multiple Sclerosis
Delaware Valley sites
- Teva Investigational Site 1258 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory